Global Health Leaders to Convene at Abu Dhabi Future Health Summit 2026
2.10.2026 13:24:00 EEST | Business Wire | Press release
Global leaders across healthcare, science, technology, policy, and investment will convene at the Abu Dhabi Future Health Summit from 20 to 22 October 2026 to examine how health systems can better anticipate risk and enable earlier intervention as advances in AI, genomics, diagnostics, and health data create new possibilities for understanding health risks earlier.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001283179/en/
Forum panel and speakers at the Abu Dhabi Future Health Summit
As health systems respond to the growing burden of chronic disease and the need to help people live longer in good health, the ability to identify changing health risks and act sooner is becoming increasingly important. Hosted by Future Health – A Global Initiative by Abu Dhabi and the Department of Health – Abu Dhabi, the Future Health Summit will be held under the theme 'To Sense is to Predict', exploring the global shift from reactive models of care towards earlier prediction, prevention, and personalised intervention.
Future Health is already translating this ambition into year-round activity. Its inaugural Future Health Challenge received 393 submissions from 68 countries with solutions already present in international communities. Additionally, the platform has released the Future of Longevity and Future of Healthy Living whitepapers, and joined the MIT Koch Institute for Integrative Cancer Research’s BioConvergence Cancer Alliance as a Founding Member. The Future Health Summit will build on this work, bringing the Future Health community together in Abu Dhabi to advance further collaboration and implementation.
With 130 Forum speakers and more than 175 exhibitors, with representation expected from 100 countries, the Summit will bring together expertise from a wide range of health systems and settings to examine how emerging approaches can work across different populations and models of care.
Featured Forum speakers include:
- His Excellency Mansoor Al Mansoori, Chairman of the Department of Health – Abu Dhabi
- Sir Pascal Soriot, CEO of AstraZeneca
- Mr. Tim Schmid, EVP & Worldwide Chairman of Johnson & Johnson MedTech
- Ms. Helga Fogstad, Director of Health, UNICEF
- Mr. Will Ahmed, Founder & CEO of WHOOP
- Mr. Tom Hale, CEO of ŌURA
- Dr. Christine Yuan Huang, Founder & CEO of Quantum Life
- Mr. Max Jaderberg, President of Isomorphic Labs
- Dr. Ola Brown, Founding Partner of HealthCap Africa
- Dr. Jayasree Iyer, CEO of Access to Medicine Foundation
- Mr. Hugo Harper, Mission Director of a Healthy Life at Nesta
They will be joined by international ministers and government representatives. This global participation brings experience of national health systems and organisations to the discussions in Abu Dhabi, reflecting the reach of the Future Health community.
Her Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: “The ability to understand health risk earlier can have a measurable impact on how health systems serve their populations. As advances in science and technology give us greater insight into health, the priority is to translate that insight into earlier action that can improves outcomes and help people live more years in good health.
“Global collaboration is fundamental to advancing this approach across different health systems and contexts. The Abu Dhabi Future Health Summit brings international expertise together with the capabilities we have built in Abu Dhabi, creating opportunities compare experience across health systems and examine how new approaches can work in practice. Abu Dhabi provides a real-world environment where that global exchange can connect directly with implementation at population scale,” she added.
At the core of the Summit is the Forum, which will feature keynotes, C-suite conversations, and public-private dialogues involving leaders from across the global health ecosystem. The Forum will explore ‘To Sense is to Predict’ at three interconnected levels - individual, health system, and population - with discussions spanning Future Health’s four thematic focus areas: Longevity and Precision Medicine; Digital Health & AI; Health System Resilience & Sustainability; and Investment in Life Sciences.
Alongside the Forum, the Global Exhibition will bring together exhibitors from across healthcare, technology, life sciences, and investment, showcasing innovations and capabilities shaping the future of health. A programme of Side Events will provide further opportunities for focused dialogue and collaboration.
The Abu Dhabi Future Health Summit is the annual flagship gathering of Future Health – A Global Initiative by Abu Dhabi, a year-round platform for global collaboration and transformative health innovation. Throughout 2026, Future Health has advanced the ‘To Sense is to Predict’ agenda through international dialogues, research and impact initiatives designed to move ideas towards real-world application.
A full list of Forum speakers, which will continue to be updated in the lead up to the event, is available on the Future Health website.
Register as a visitor: Future Health Summit Visitor Registration
Media registrations are welcome at: Future Health Summit Media Registration
About Future Health – A Global Initiative by Abu Dhabi
Future Health is a year-round platform for global collaboration and transformative health innovation, held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council.
Bringing together health researchers, policymakers, business leaders, investors and entrepreneurs from across disciplines and geographies, Future Health drives collective action to strengthen health systems and unlock longer, healthier lives for all.
Through a year-round programme of research insights, publications, impact initiatives, Challenges, R&D funding, and cross-sector convenings, Future Health advances progress across four focus areas: longevity and precision medicine, health systems and sustainability, digital health and AI, and investment in life sciences.
Future Health is curated and convened by the Department of Health – Abu Dhabi and its Founding Partners PureHealth, M42, Institute for Healthier Living Abu Dhabi, and Mubadala Bio. Mediclinic Middle East serves as Strategic Partner and Burjeel Holdings as Associate Partner.
For more information, visit www.futurehealthinitiative.ae and follow Future Health on: X, Instagram, LinkedIn and Facebook.
About the Department of Health – Abu Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the Emirate of Abu Dhabi and ensures excellence in healthcare by monitoring the health status of the population. DoH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system. In addition, DoH shapes the regulatory framework for the health system, inspects against regulations, enforces standards, and encourages adoption of world-class best practices and performance targets by all healthcare service providers in the Emirate. DoH also drives programmes to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system.
For further information on DOH, visit https://www.doh.gov.ae/ and follow on Twitter, Instagram, Facebook, LinkedIn and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261001283179/en/
Contacts
Media Enquiries
For media enquiries, interview requests and accreditation opportunities, please
contact: media@futurehealthinitative.ae
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NIQ Brings New AI and Automation Capabilities to Retail Space Planning and Merchandising2.10.2026 13:45:00 EEST | Press release
NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced new AI and automation capabilities for NIQ Spaceman®, its retail space planning and merchandising platform trusted by more than 600 retailers across 65+ countries. The enhancements help retailers create store-specific planograms up to 50 times faster, identify execution and compliance gaps, and scale merchandising decisions across their store networks through expanded cloud-based access. "Retailers are under increasing pressure to localize assortments, execute consistently across stores, and respond more quickly to changing shopper behavior," said Natalie Williams, SVP, Product at NIQ. "These enhancements help simplify that process by embedding agentic AI directly into merchandising workflows and automating traditionally manual planning tasks. That means teams can spend less time building and updating planograms and more time acting on opportunities. With greater automation, retailers can improve productivi
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2.10.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to one senior leader and ten newly hired non-executive employees. The equity awards for the senior leader were granted on September 30, 2026 and consisted of options to purchase an aggregate of 121,800 shares and restricted share units covering an aggregate of 58,000 shares. The options have an exercise price per share equal to $12.44. The equity awards to the ten newly hired non-executive employees were granted on October 1, 2026 and consisted of options to purchase an aggregate of 97,100 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 46,200 shares. These options have an exercise price per share equal to $11.95, the closing price of the Company’s American De
Venture Global and ConocoPhillips Announce 20-Year LNG Sales and Purchase Agreement1.10.2026 23:30:00 EEST | Press release
Today, Venture Global, Inc. (NYSE: VG) and ConocoPhillips (NYSE: COP) announced a new, long-term Sales and Purchase Agreement (SPA) for liquefied natural gas (LNG). Under the SPA, ConocoPhillips will buy 1.0 million tonnes per annum (MTPA) of LNG from Venture Global for 20 years, starting in 2030. "Venture Global is proud to welcome ConocoPhillips, one of the world's leading energy companies, as a long-term partner," said Venture Global CEO Mike Sabel. "This agreement reflects continued market confidence in our proven ability to deliver reliable, low-cost U.S. LNG quickly and at scale. We look forward to supporting ConocoPhillips' growing global LNG portfolio for decades to come." About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (LNG) with over 100 MTPA of capacity in production, construction, or development. Venture Global began producing LNG from its first facility in 2022 and is now one of the largest LNG exporters in th
UL Solutions Inc. Completes Acquisition of Eurofins Scientific’s Electrical & Electronics Business1.10.2026 23:05:00 EEST | Press release
UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced it has completed the acquisition of the electrical and electronics (E&E) business of Eurofins Scientific SE. “This acquisition extends our 132-year commitment to our mission of working for a safer world,” said President and CEO Jennifer Scanlon. “We are thrilled to welcome our new colleagues to UL Solutions. By bringing together complementary expertise and capabilities, we are expanding our global footprint, enhancing our TIC services for electrical safety and connected products, and adding services that support customers around the world.” Eurofins’ E&E business provides testing, compliance and certification services that support global market access for electromagnetic compatibility and wireless testing, electrical safety, medical devices and other technologies. The acquisition adds laboratories and accreditations in EMEA, Asia and the United States to UL Solutions’ global network. About UL Solu
Barnes Aerospace Acquires ATL Turbine Services, Establishing First Aeroengine Component Repair Operation in Europe1.10.2026 21:50:00 EEST | Press release
Barnes Aerospace, a global provider of component engineering, manufacturing and repair solutions for the aerospace industry, today announced the acquisition of ATL Turbine Services Ltd. ("ATL Turbine Services"), a Dundee, Scotland-based specialist in the refurbishment and repair of hot-section gas turbine components, marking Barnes Aerospace's first dedicated component repair and overhaul presence in Europe. The acquisition establishes Barnes Aerospace's initial Component Repair and Overhaul (CRO) footprint in Europe, expanding the company's aftermarket presence and strengthening its ability to serve customers in the region. ATL Turbine Services brings established in-region repair, assessment, coating, and engineering capabilities that complement Barnes Aerospace's existing global repair network and broaden the company's ability to support customers throughout the turbine engine component lifecycle. "Establishing our Component Repair and Overhaul presence in Europe is an important part
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom